Dec. 9 at 10:42 AM
$ETON: The Inflection Point is Here
The market is sleeping on the structural shift at Eton. This isn't just a revenue story; it's a profitability breakout.
1️⃣ Execution Machine: 19 consecutive quarters of growth. Q3 Rev +129% YoY (
$22.5M). Owned assets like INCRELEX are pushing Gross Margins toward 70%. Operating leverage is kicking in.
2️⃣ De-Risked Pipeline:
ET-600: Bioequivalence aced. PDUFA Feb 2026. Minimal bio-risk.
Amglidia: Leveraging European Real-World Evidence (RWE). Smart strategy.
3️⃣ Technical Setup: The daily chart is textbook. We are flagging above the 200SMA and just bounced perfectly off the long-term rising support trendline (blue line) at ~
$16. Consolidation looks healthy and ready for the next leg up.
4️⃣ Valuation: Trading ~6x Sales with >100% growth. Analyst PT
$30 (~78% upside).
~
$37M Cash. Fully funded. Short interest ~10%+ adds squeeze potential.
Opinion only. DIY DD.
